Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
BMJ Neurol Open ; 4(1): e000264, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35663590

RESUMO

Introduction: Epilepsy is closely related to daily rhythms, such as the sleep-wake cycle. The objective of this study was to evaluate the relationship between drug-resistant temporal lobe epilepsy (TLE) and the parameters related to the sleep-wake cycle, seizure time and epilepsy laterality. Methods: Consecutive patients admitted to the video electroencephalogram unit with a diagnosis of TLE were enrolled. Patients were divided into two groups: those with left TLE (LTLE) and those with right TLE (RTLE). They then remained in the conditions of 12-hour light, 12-hour darkness. Demographic data, treatment, number and time of seizure occurrence, sleep diary, morningness-eveningness questionnaire, Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale were recorded. Results: In total, 74 patients with TLE, 43 with LTLE and 31 with RTLE, were studied. RTLE patients showed a significant preference for morningness. Patients treated with benzodiazepines showed worse sleep quality and greater daytime sleepiness. Patients who did not report any clear predominance and patients who reported seizures during wakefulness had significantly more seizures during wakefulness and patients who reported sleep predominance had more seizures during sleep (p>0.001). The LTLE group had a greater number of seizures from 8 to 16 hours, unlike the RTLE group, which had a uniform distribution (p=0.008). Conclusions: This was a prospective study of patients with drug-resistant TLE performed in a controlled environment to study the impact of daily rhythms, seizure frequency and seizure distribution. Laterality seems to be a key factor in seizure distribution.

2.
Acta Neurol Belg ; 112(1): 81-4, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22427296

RESUMO

Topiramate is a sulfamate-substituted monosaccharide mainly used to treat epilepsy in children and adults and prophylaxis of migraine. This article describes a case of topiramate-induced acute transient myopia. The underlying mechanism and management is discussed. A 13-year-old female complained of sudden onset of blurred vision; 7 days prior to this she had commenced topiramate therapy for migraine prophylaxis. Visual acuity was reduced in both eyes. Examination revealed myopic refractive changes which resolved quickly following discontinuation of the drug. An MRI showed uveoscleral and subcutaneous cellular tissue abnormalities in the T1 contrasted images.


Assuntos
Frutose/análogos & derivados , Miopia/induzido quimicamente , Miopia/diagnóstico , Fármacos Neuroprotetores/efeitos adversos , Adolescente , Meios de Contraste , Feminino , Frutose/efeitos adversos , Cefaleia/tratamento farmacológico , Humanos , Imageamento por Ressonância Magnética , Topiramato
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA